Ariaus Biosciences Private Limited
About Ariaus Biosciences Private Limited
Data last updated:
Ariaus Biosciences Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U36912UP2016PTC075600. Its GSTIN is 09AAOCA0518Q1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Amit Kumar Shukla and Shubhashish Shukla.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at P No. 58 Amritpuram Koyala Nagar, Kanpur, Uttar Pradesh, India – 208011.
As per the financials filed for FY 2022, the company reported a revenue of ₹80.87 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4,098 (net margin 0.1%) and EBITDA of ₹8,848 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 106% over three years and 179% over five years.
As per MCA filings, the company has open charges of ₹35 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ariaus Biosciences Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP No. 58 Amritpuram Koyala Nagar, Kanpur, Uttar Pradesh, India – 208011
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ariaus Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ariaus Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ariaus Biosciences Private Limited, buy the company report.
Financials of Ariaus Biosciences Private Limited
FY 2022 filings availableAriaus Biosciences Private Limited reported revenue of ₹80.87 Lakh (up 192% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 179% over five years, including 192% growth in the latest year. EBITDA rose 229% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,848 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,098 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ariaus Biosciences Private Limited, buy the company report.
Board of directors of Ariaus Biosciences Private Limited
Ariaus Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Shukla | Director | 08 Jan 2016 | 10 Years 9 Months | Current |
| Shubhashish Shukla | Director | 08 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Ariaus Biosciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Biosciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kadam Packmat Private Limited | ₹81.12 Lakh (FY 2020) | 102.0% | Ahmedabad, Gujarat, India | |||
| Aaztrazivixa Life Sciences Private Limited | ₹81.02 Lakh (FY 2025) | -19.0% | Muvattupuzha, Kerala, India | |||
| Orange Chemists Private Limited | ₹80.96 Lakh (FY 2020) | -38.0% | Pune, Maharashtra, India | |||
| Pee Dee Pharma Pvt Ltd | ₹80.92 Lakh (FY 2025) | -26.0% | Kolkata, West Bengal, India | |||
| Ariaus Biosciences Private Limitedthis company | ₹80.87 Lakh (FY 2022) | ₹4,098 | 0.1% | 192.0% | Kanpur, Uttar Pradesh, India | |
| Soyuz Healthcare Private Limited | ₹80.75 Lakh (FY 2018) | 482.0% | Delhi, India | |||
| JSBM Pharma Private Limited | ₹80.69 Lakh (FY 2025) | 182.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Ariaus Biosciences Private Limited, buy the company report.
Auditor
Ariaus Biosciences Private Limited is audited by DEEP MISRA & COMPANY for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEP MISRA & COMPANY | FY 2020 | 009678C |
Shareholding
The shareholding of Ariaus Biosciences Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ariaus Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Nov 2022 | 100661668 | Others | ₹35 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Ariaus Biosciences Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Zenex Animal Helath India Pvt Ltd | Disposed |
To see the full case history of Ariaus Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ariaus Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ariaus Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAOCA0518Q1Z6 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ariaus Biosciences Private Limited, buy the company report.
Recent activity
Ariaus Biosciences Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Amit Kumar Shukla was appointed as Director on 08 Jan 2016.
Frequently asked questions
Ariaus Biosciences is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 January 2016 (10+ years old) and is registered under CIN U36912UP2016PTC075600.
Ariaus Biosciences has 2 current directors:
- Amit Kumar Shukla - Director
- Shubhashish Shukla - Director
The latest financial statements of Ariaus Biosciences on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ariaus Biosciences is 09AAOCA0518Q1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ariaus Biosciences is U36912UP2016PTC075600. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ariaus Biosciences has 1 court case on record: 1 filed against it.
Ariaus Biosciences was incorporated on 08 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Ariaus Biosciences by revenue are Kadam Packmat Private Limited, Aaztrazivixa Life Sciences Private Limited, Orange Chemists Private Limited, Pee Dee Pharma Pvt Ltd, Soyuz Healthcare Private Limited and 1 more, all in the Pharma industry (Biosciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Amit Kumar Shukla was appointed as Director on 08 Jan 2016. Shubhashish Shukla was appointed as Director on 08 Jan 2016.
The registered office of Ariaus Biosciences is at P No. 58 Amritpuram Koyala Nagar, Kanpur, Uttar Pradesh, India – 208011.
Ariaus Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
